Iol with drug delivery devices and uninterrupted pco barrier edge

Abstract

An ophthalmic implant including an intraocular structure with an anterior side, a posterior side opposite the anterior side, a central portion, a circumferential side wall circumscribing the central portion, and a haptic coupled to and extending outwards from the circumferential side wall The ophthalmic implant includes a drug delivery device attachable to the intraocular structure. The drug delivery device includes an anterior panel having an anterior panel side wall, an attachment structure extending posteriorly from the anterior panel and defining an opening for receiving the haptic therethrough, and one or more therapeutic agents dispersed within a polymer matrix positioned within the anterior panel. The attachment structure is devoid of the one or more therapeutic agents.

Dependencies are inferred from the claim text.